Global D Bioprinting Market By Overview
3D bioprinting is the technique to combine growth factors, cells, and biomaterials to assemble biomedical parts that maximally imitate natural tissue characteristics. The technique is widely applicable to the fields of bioengineering and medicine. Recently, the technology has made various advancements in the production of cartilage tissue for use in regeneration and reconstruction.
Growing applications of 3D bioprinted tissue and hair follicles as they are very beneficial to cosmetics companies is the major factor driving growth of the global 3D bioprinting market. In addition, rising government support is also fascinating many investors to invest in R&D programs, which is anticipated to boost growth of the global market over the forecast period. In 2018, Mapp Biopharmaceutical Inc. announced that it had been awarded a contract of US$ 14.8 Mn by the Biomedical Advanced Research and Development Authority (BARDA), with options for an additional US$ 32.0 Mn. Moreover, numerous research institutes and universities have invested in the development of better quality and highly efficient bio-implants at low costs, thus propelling growth of the global market. For instance, in January 2019, The Institute for Technology Inspired Regenerative Medicine in Netherlands has collaborated with Aspect Biosystems, a Canadian company, for the developments in regenerative medicine and 3D printing.
The global 3D bioprinting market is segmented based of technology, component, application, and region.
Based on technology, the global 3D bioprinting market is segmented into syringe/extrusion bioprinting, inkjet bioprinting, magnetic levitation bioprinting, and laser-assisted bioprinting. Syringe-based technology segment is projected to have the largest market share for 3D bioprinting; owing to rise in the adoption of 3d bioprinting technique by innovators is a vital factor that promotes the growth of this segment. On the basis of component, the target market is bifurcated into 3D bioprinters, biomaterials, and scaffolds. Based on applications, the target market is segmented into drug testing and development, regenerative medicine, food testing, and research. Research application segment will dominate the global market over the forecast period owing to its wide use in 3D cell culture and regenerative medicine.
Based on region the global 3D bioprinting market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is dominating the global market over the forecast period. The presence of sophisticated healthcare infrastructure and well-established companies along with high disposable income levels in the region are also expected to dominate the global market in the region. In addition, extensive research activities conducted within the region are also responsible for the global market growth. Asia-Pacific is the fastest growing market for 3D bioprinting, owing to huge scope of 3D printing in medical services, increasing R&D for 3D printing, and government support and tax incentives. Rising number of cancer cases and the increasing the number of cancer treatments in the region are also expected to fuel the adoption of 3D bioprinting technology. According to the World Cancer Research Fund, the cancer rate is the highest in New Zealand and Australia in the world.
Key players operating in the global 3D bioprinting market includes 3D Systems Corporation, Aspect Biosystems Ltd., GeSIM GmbH, Bio3D Technologies, Allevi, Inc., Cyfuse Biomedical KK, Aprecia Pharmaceuticals, Organovo Holdings Inc., Dynamic Systems Ltd., and RegenHU SA. Technological advancements in the product as well as in manufacturing process, product launches, and strategic partnerships are some trends witnessed in the global market. For instance, in March 2016, Aprecia Pharmaceuticals, a U.S.-based pharma company, received approval for the 3D printing for the drug Spritam. It’s the first-ever USFDA approval. The drug has therapeutic action in the treatment of epileptic patients.
Detailed Segmentation:
Global 3D Bioprinting Market, By Technology:
- Syringe/Extrusion Bioprinting
- Inkjet Bioprinting
- Magnetic Levitation Bioprinting
- Laser-assisted Bioprinting
Global 3D Bioprinting Market, By Component:
- 3D Bioprinters
- Biomaterials
- Scaffolds
Global 3D Bioprinting Market, By Application:
- Drug Testing and Development
- Regenerative Medicine
- Food Testing
- Research
Global 3D Bioprinting Market, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profile:
- 3D Systems Corporation *
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Aspect Biosystems Ltd.
- GeSIM GmbH
- Bio3D Technologies
- Allevi, Inc.
- Cyfuse Biomedical KK
- Aprecia Pharmaceuticals
- Organovo Holdings Inc.
- Dynamic Systems Ltd.
- RegenHU SA
“*” marked represents similar segmentation in other categories in the respective section
Global D Bioprinting Market By Table of Contents
Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Technologys
- Key Thickness Insights
- Secondary Data
- Major Secondary Technologys
- Secondary Technologys
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
Market Preview
- Executive Summary
- Key Findings—Global Outlook for medical carts Strategies
- Key Questions this Study will Answer
- Market Snippet, By Technology
- Market Snippet, By Component
- Market Snippet, By APPLICATION
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restrains
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
3D Bioprinting Market, By Technology, Forecast Period up to 10 Years, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Syringe/Extrusion Bioprinting
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Inkjet Bioprinting
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Magnetic Levitation Bioprinting
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Laser-assisted Bioprinting
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
3D Bioprinting Market, By Component, Forecast Period up to 10 Years, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- 3D Bioprinters
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Biomaterials
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Scaffolds
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
3D Bioprinting Market, By APPLICATION, Forecast Period up to 10 Years, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Drug Testing
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Development
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Regenerative Medicine
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Food Testing
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
3D Bioprinting Market, By Region, Forecast Period up to 10 Years, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Regional Trends
- North America
- Market Size and Forecast (US$ Bn), By Technology, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Component, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By APPLICATION, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Bn), By Technology, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Component, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By APPLICATION, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Bn), By Technology, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Component, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By APPLICATION, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Bn), By Technology, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Component, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By APPLICATION, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Bn), By Technology, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Component, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By APPLICATION, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- GCC
- Israel
- South Africa
- Rest of Middle East
Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
Company Profiles
- Aspect Biosystems Ltd.
- Company Overview
- Technology Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- GeSIM GmbH
- Company Overview
- Technology Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Bio3D Technologies
- Company Overview
- Technology Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Allevi, Inc.
- Company Overview
- Technology Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Cyfuse Biomedical KK
- Company Overview
- Technology Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Aprecia Pharmaceuticals
- Company Overview
- Technology Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Organovo Holdings Inc.
- Company Overview
- Technology Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Dynamic Systems Ltd.
- Company Overview
- Technology Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
The Last Word
- Future Impact
- About Us
- Contact
FAQs
The global 3D bioprinting market accounted for US$ 470.38 billion in 2019 and is projected to register a moderate CAGR of 24.60% over the forecast period.
The market report has been segmented based on technology, component, application, and region.
Emerging trends include the use of advanced biomaterials for bioprinting, the development of personalized and on-demand tissue and organ manufacturing, and collaborations between biotech companies and research institutions, presenting significant opportunities in the global 3D Bioprinting Market.
Factors driving the market include advancements in bioprinting technologies, the growing demand for organ transplantation solutions, increasing research and development activities in regenerative medicine, and the potential for personalized medicine applications.
The report covers regions worldwide. North America is expected to dominate the 3D Bioprinting Market, driven by a strong presence of biotech companies, significant research and development initiatives, and a favorable regulatory environment supporting innovation in the region.
The prominent player operating in the global 3D Bio-Printing market includes 3D Systems Corporation, Aspect Biosystems Ltd., GeSIM GmbH, Bio3D Technologies, Allevi, Inc., Cyfuse Biomedical KK, Aprecia Pharmaceuticals, Organovo Holdings Inc., Dynamic Systems Ltd., and RegenHU SA.